Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by BlueFranky on Nov 17, 2024 11:51am

This is TLT

And I'm not alone when I kindly request that all those who wish to pursue conversations around anything but TLT, please take these conversations elsewhere.

Thank you
Comment by Eoganacht on Nov 17, 2024 1:04pm
You are certainly not alone BlueFranky. Maybe someone could create a TLT Shareholder Politics Chat Group where those who feel a need to proclaim their political views and oppose those with conflicting views can indulge themselves to their heart's content.
Comment by BlueFranky on Nov 17, 2024 1:12pm
Thanks, Eog!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities